Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan.

Eisai Clinical Trials

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer’s disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan.

Protocol # E2020-J081-161

Study Overview

Study Compound: E2020

Drug Name: donepezil

Registry #: Not available

Trial Period: -

Indication: Alzheimer's disease

Primary Endpoint:

Population
Study Status
Completed
Study Phase
Phase 1
Countries
Japan

Results

CSR Synopsis

No download available

Lay Summary

No download available

Publication reference citation

Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, et al. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer’s disease. A 24-week,multicenter double-blind, placebo-controlled study in Japan. Dementia and Geriatric Cognitive Disorders. 2000;11:299-313.

Data Sharing

ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.

Redacted documents are available upon request for this study.

Document type	Availability
Protocol
SAP
Sample CRF
Full CSR